Bonzun AB (publ) (BONZUN.ST)
SEK 0.01
(-2.78%)
SEK 0.01
(-2.78%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.11 SEK | 106.64% |
| 2022 | -1.26 SEK | -6939.11% |
| 2021 | -0.02 SEK | 98.97% |
| 2020 | -1.74 SEK | 48.82% |
| 2019 | -3.40 SEK | -1.19% |
| 2018 | -3.36 SEK | 93.76% |
| 2017 | -53.86 SEK | -48.09% |
| 2016 | -36.37 SEK | -23.5% |
| 2015 | -29.45 SEK | -21.44% |
| 2014 | -24.25 SEK | 34.51% |
| 2013 | -37.03 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.12 TRY | -88.38% |
| 2024 Q1 | -0.06 SEK | 69.67% |
| 2023 Q4 | -0.21 SEK | -231.25% |
| 2023 Q1 | -0.16 SEK | 78.38% |
| 2023 Q2 | -0.04 SEK | 78.06% |
| 2023 FY | - SEK | 106.64% |
| 2023 Q3 | 0.16 SEK | 555.84% |
| 2022 Q4 | -0.74 SEK | -640.0% |
| 2022 Q2 | -0.13 SEK | 62.86% |
| 2022 Q1 | -0.35 SEK | -300.92% |
| 2022 FY | - SEK | -6939.11% |
| 2022 Q3 | -0.10 SEK | 23.08% |
| 2021 Q3 | -0.29 SEK | 0.0% |
| 2021 FY | - SEK | 98.97% |
| 2021 Q4 | -0.09 SEK | 69.9% |
| 2020 FY | - SEK | 48.82% |
| 2020 Q3 | -0.39 SEK | 0.0% |
| 2020 Q4 | -0.58 SEK | -48.72% |
| 2019 FY | - SEK | -1.19% |
| 2018 FY | - SEK | 93.76% |
| 2017 FY | - SEK | -48.09% |
| 2016 FY | - SEK | -23.5% |
| 2015 FY | - SEK | -21.44% |
| 2014 FY | - SEK | 34.51% |
| 2013 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aino Health AB (publ) | -0.08 SEK | 229.717% |
| Kontigo Care AB (publ) | 0.01 SEK | -1150.0% |
| Medhelp Care Aktiebolag (publ) | -0.36 SEK | 130.556% |
| RaySearch Laboratories AB (publ) | 2.38 SEK | 95.378% |
| Surgical Science Sweden AB (publ) | 4.59 SEK | 97.603% |